| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02824913 Details | 2018-08-31 Interventional | 2 | 1 | Ophthalmic Solu… Pharmaceutical … Dry Eye Syndrom… Eye Diseases Keratoconjuncti… Dry Eye Disease | - - | |||
| NCT01842334 Details | 2018-08-31 Interventional | 1/2 | 22 | Nicotine Tobacco Use Dis… Nicotine Depend… Smoking Cessati… | left institution protocol closed Due to lack of sufficient funds/resources, the sample size for this study is not large enough to extract any conclusive results. The high number of subjects withdrawing from the study early also hinders any possible conclusions. | |||
| NCT01267825 Details | 2018-08-31 Interventional | 4 | 1 | Bupivacaine Hernia Intervertebral … Radiculopathy Disc Herniation Lumbosacral Rad… | Study terminated early due to low enrollment. No data collected. - | |||
| NCT01015677 Details | 2018-08-31 Interventional | 2 | 99 | Estradiol Estradiol 17 be… Estradiol 3-ben… Polyestradiol p… Moderate to Sev… Women | - The study was terminated at the end of Stage 1 so no participants entered Stage 2 and no participants received MK-6913 25 mg. | |||
| NCT01621243 Details | 2018-08-29 Interventional | 1/2 | 128 | Albumin-Bound P… Gemcitabine Paclitaxel Pancreatic Neop… Metastatic Panc… | The study was terminated after a pre-planned futility analyses showed an insufficient level of
efficacy in the study population to warrant continuation. - | |||
| NCT01534351 Details | 2018-08-29 Interventional | 3 | 1 | Finasteride Tamsulosin Hyperplasia Prostatic Hyper… Benign Prostati… | Business Reasons The trial was terminated for business reasons. | |||
| NCT00632970 Details | 2018-08-29 Interventional | 4 | 6 | Emtricitabine Emtricitabine, … Lopinavir Raltegravir Pot… Ritonavir Tenofovir HIV Infections | no patients completed - | |||
| NCT03182894 Details | 2018-08-28 Interventional | 1/2 | 0 | Azacitidine Pembrolizumab Colorectal Neop… Metastatic Colo… | Study will not be conducted due to changes related to the investigational agent. - | |||
| NCT02974114 Details | 2018-08-28 Interventional | 4 | 21 | Acetaminophen Caffeine Pain | - The study was terminated early due to breaches of GCP guidelines observed during a GSKCH internal audit. The minimum requirement of 8 subjects per strata was not met because of early termination so some exploratory analyses were not conducted. | |||
| NCT02397356 2014-000837-22 Details | 2018-08-28 Interventional | 4 | 0 | Ketamine Pain, Postopera… | Lack of study personnel - | |||
| NCT00804830 2007-001783-75 Details | 2018-08-28 Interventional | 2 | 15 | Bevacizumab Doxorubicin Thyroid Carcino… Thyroid Disease… Thyroid Neoplas… Carcinoma Metastatic Canc… Thyroid Cancer | lack of response - | |||
| NCT02864628 Details | 2018-08-27 Interventional | 1 | 0 | Smallpox and mo… Respiratory Syn… | Protocol was withdrawn from IND - | |||
| NCT01756105 Details | 2018-08-27 Interventional | 2 | - | Insulin Insulin, Isopha… Isophane Insuli… Isophane insuli… Metformin Diabetes Mellit… Diabetes, Gesta… Gestational Dia… Metformin Oxidative Stres… Treatment | - - | |||
| NCT01716234 2007-004645-15 Details | 2018-08-27 Interventional | 1 | 142 | Posaconazole Mycoses Fungal Infectio… | Study was terminated early (10 July 2015) based on preliminary analysis of pharmacokinetic
data. Only 1 participant was enrolled in the POS 12 TID 3 months to <2 years group, limiting conclusions that may be drawn for pharmacokinetics or safety. | |||
| NCT00960063 Details | 2018-08-27 Interventional | 1 | 4 | Cyclophosphamid… Doxorubicin Etoposide Ifosfamide Irinotecan Temozolomide Vincristine Bone Neoplasms Kidney Neoplasm… Neoplasms Neuroblastoma Bone Cancer Kidney Tumor Solid Tumors | Study was terminated for business reasons. - | |||
| NCT00907517 Details | 2018-08-27 Interventional | 1 | 24 | Cytarabine Leukemia Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Precursor Cell … Leukemia, Lymph… Leukemia, Lymph… Myelogenous Leu… Myelogenous Leu… | - - | |||
| NCT00427297 Details | 2018-08-27 Interventional | 3 | 34 | Abacavir Didanosine Dideoxynucleosi… Efavirenz Lamivudine Lopinavir Nevirapine Ritonavir Stavudine Tenofovir Zidovudine HIV Infections | There is no longer equipoise. DSMB recommended termination. The study team suggested discontinuation of the trial and the DSMB concurred based on slow accrual and based on new data that emerged after the RCT was initiated which made the trial question less relevant. | |||
| NCT02483598 Details | 2018-08-24 Interventional | 4 | - | Buspirone Gastric Bypass | Initial analysis of results warranted a study re-design and work on the study was suspended. - | |||
| NCT01868906 2009-015852-11 Details | 2018-08-24 Interventional | 2 | 6 | Temozolomide Glioma Malignant Gliom… | Isotope (FMISO) production is no longer available in our country. - | |||
| NCT01678820 Details | 2018-08-24 Interventional | 3 | 299 | Glimepiride Metformin Simvastatin Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes… | Merck terminated the study for business reasons in November 2013. Study was terminated for business reasons in November 2013. |